COLLEGIUM PHARMACEUTICAL, INC (COLL) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $27.7 M.
  • Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was $93.3 M.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2023 was $48.2 M.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$25 M, a 135% decline from 2021.
  • Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2021 was $71.5 M, a 167% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $93.3 M $27.7 M +$45.1 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $48.2 M $31.9 M +$39.1 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $9.02 M $20.6 M +$20.2 M +4415% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 -$11.2 M $13 M +$18.2 M Apr 1, 2023 Jun 30, 2023 10-K 2024-02-22
Q1 2023 -$29.4 M -$17.4 M -$4.36 M -33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$25 M -$7.2 M +$17.8 M +71.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$42.8 M $457 K -$7.59 M -94.3% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 -$35.2 M -$5.19 M -$78 M -107% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 $42.8 M -$13.1 M -$28.7 M -183% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $71.5 M -$25 M -$32 M -460% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $104 M $8.05 M -$3.24 M -28.7% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $107 M $72.8 M +$64.8 M +804% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $42 M $15.7 M +$15.2 M +3380% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $26.8 M $6.96 M +$9.16 M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $17.6 M $11.3 M +$17.4 M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $198 K $8.06 M +$12.8 M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 -$12.6 M $450 K +$10.2 M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 -$22.7 M -$2.2 M -$11.3 M -124% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$11.4 M -$6.11 M +$10.4 M +63% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$21.8 M -$4.71 M +$8.35 M +63.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$30.2 M -$9.7 M +$8.95 M +48% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$39.1 M $9.09 M +$26.5 M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$65.6 M -$16.5 M -$3.24 M -24.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$62.4 M -$13.1 M +$8.06 M +38.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$70.4 M -$18.7 M +$4.43 M +19.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$74.9 M -$17.4 M +$10.2 M +36.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$85 M -$13.3 M +$13.2 M +49.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$98.2 M -$21.1 M +$3.4 M +13.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$102 M -$23.1 M -$7.43 M -47.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$94.2 M -$27.6 M -$18 M -189% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$76.1 M -$26.4 M -$17.1 M -182% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$59.1 M -$24.5 M -$19.8 M -425% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$39.2 M -$15.7 M -$12 M -324% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$27.3 M -$9.53 M -$6.06 M -175% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$21.2 M -$9.36 M -$2.81 M -42.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$18.4 M -$4.67 M -$557 K -13.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$17.8 M -$3.69 M +$81 K +2.15% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$17.9 M -$3.47 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$6.56 M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$4.12 M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$3.78 M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.